The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Monakhov S.A.

I.M. Sechenov Moscow Medical Academy

Advanced options in the treatment of acne using zinc-erythromycin complex

Authors:

Monakhov S.A.

More about the authors

Read: 11640 times


To cite this article:

Monakhov SA. Advanced options in the treatment of acne using zinc-erythromycin complex. Russian Journal of Clinical Dermatology and Venereology. 2017;16(5):49‑57. (In Russ.)
https://doi.org/10.17116/klinderma201716549-57

Recommended articles:
Study of the role of inte­rleukin-1β in blood serum in patients with acne. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):421-424
Adhe­rence of patients to acne therapy using systemic isotretinoin. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):483-488
Clinical discussion of patients with follicular occlusion syndrome and como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):596-603
Rational choice of combined therapy of acne: systemic isotretinoin and high-energy hardware technologies. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):651-656

References:

  1. Monakhov SA. Zineryt lotion in the therapy of acne. Pharmateka. 2007;10:52-57. (In Russ.)
  2. Monakhov SA. Rational therapy of acne. Rossiyskiy journal kozhnykh i venericheskyh bolezney. 2013; 6:47-54. (In Russ.)
  3. Monakhov SA, Ivanov OL. Acne. Ethiopathogenesis, clinics and therapy. Clinical guidance for practitioners. M. 2012;32. (In Russ.)
  4. Samgin MA, Monakhov SA. Acne (lecture). Rossiyskiy journal kozhnykh i venericheskyh bolezney. 2005; 3:55-66. (In Russ.)
  5. Sergeev AJu, Burtseva GN, Sergeev VJu. Pharmacoepidemiology of acne and anonymous evaluation by patients. Immunopathologiya, allergologiya, infectologiya. 2012; 4:102-111. (In Russ.)
  6. Abou-Mohamed G, Papapetropoulos A, Catravas JD et al. Zn2+ inhibits nitric oxide formation in response to ipopolysaccharides: implications in its anti-inflammatory activity. Eur J Pharmacol. 1998;341:265-272.
  7. Bray TM, Bettger WJ. The physiological role of zinc as an antioxidant. Free Radic Biol Med. 1990;8:281-291.
  8. Chu A, Huber FJ, Plott RT. The comparative efficacy of benzoyl peroxide 5%/erythromycin 3% gel and erythromycin 4%/zinc 1.2% solution in the treatment of acne vulgaris. Br J Dermatol. 1997;136(Suppl. 2):235-238.
  9. Dreno B, Bettoli V, Ochsendorf F, et. al. European recommendations on the use of oral antibiotics for acne. Eur J Dermatol. 2004;14:391-399.
  10. Eady AE, Cove JH, Layton AM. Is antibiotic resistance in cutaneous propionibacteria clinically relevant? Implications of resistance for acne patients and prescribers. Am J Clin Dermatol. 2003;4:813-831.
  11. Eady EA, Gloor M, Leyden JJ. Propionibacterium acnes resistance: a worldwide problem. Dermatology. 2003;206:54-56.
  12. Feucht CL, Allen BS, Chalker DK, Smith JG Jr. Topical erythromycin with zinc in acne. A double-blind controlled study. J Am Acad Dermatol. 1980; 3(Suppl. 5):483-491.
  13. Gollnick H, Cunfliffe W, Berson D et. al. Management of acne: A report form a global alliance to improve outcomes in acne. J Am Acad Dermatol. 2003;49(Suppl.1):1-37.
  14. Guéniche A, Viac J, Lizard G et al. Protective effect of zinc on keratinocyte activation markers induced by interferon or nickel. Acta Derm Venereol. 1995;75:19-23.
  15. Habbema L, Koopmans B, Menke HE, et al. A 4% erythromycin and zinc combination (Zineryt) versus 2% erythromycin (Eryderm) in acne vulgaris: a randomized, double-blind comparative study. Br J Dermatol. 1989; 121(Suppl. 4):497-502.
  16. Hoogdalem EJ, Terpstra IJ, Baven ALM. Evaluation of the effect of zinc acetate on the stratum corneum penetration kinetics of erythromycin in healthy male volunteers. Skin Pharmacol. 1996;9:104-110.
  17. Jarrousse V, Castex-Rizzi N, Khammari A, et al. Zinc salts inhibit in vitro toll-like receptor 2 surface expression by keratinocytes. Eur J Dermatol. 2007;17(Suppl. 6):492-496.
  18. Langner A, Sheehan-Dare R, Layton A. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris. J Eur Acad Dermatol Venereol. 2007;21(Suppl. 3):311-319.
  19. Lansdown AB, Mirastschijski U, Stubbs N, et al. Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair Regen. 2007;15(Suppl. 1):2-16.
  20. Levy RM, Huang EY, Roling D, et. al. Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch Dermatol. 2003;139:467-471.
  21. Mobacken H. Oral tetracycline-treatment of acne. Rapid facial improvement, but back lesions are more difficult to treat. Lakartidningen. 1993;90:2755-2757.
  22. Oprica C, Nord CE. ESCMID Study Group on antimicrobial resistance in anaerobic bacteria. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin Microbiol Infect. 2005;11(Suppl. 3):204-213.
  23. Piérard-Franchimont C, Coffin V, Visser JN, Jacoby H, Piérard GE. A double-blind controlled evaluation of the sebosuppressive activity of topical erythromycin-zinc complex. Eur J Clin. Pharmacol. 1995;49:57-60.
  24. Richard MJ, Guiraud P, Leccia MT, et al. Effect of zinc supplementation on resistance of cultured human skin fibroblasts toward oxidant stress. Biol Trace Elem Res. 1993;37:187-199.
  25. Record IR, Jannes M, Dreosti IE. Protection by zinc against UVA and UVB-induced cellular and genomic damage in vivo and in vitro. Biol Trace Elem Res. 1996;53:19-25.
  26. Ross JI, Snelling AM, Carnegie E, et. al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol. 2003;148:467-478.
  27. Rostan E, DeBuus HV, Madey DL, et al. Evidence supporting zinc as an important antioxidant for skin. Int J Dermatol. 2002;41:606-611.
  28. Schachner L, Pestana A, Kittles C. A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation. J Am Acad Dermatol. 1990;22(Suppl. 3):489-495.
  29. Stainforth J, MacDonald-Hull S, Papworth-Smith JW, et al. Single-blind comparison of topical erythromycin/zinc lotion and oral minocycline in the treatment of acne vulgaris. J Dermatol Treat. 1993;4:119-122.
  30. Strauss JS, Stranieri AM. Acne treatment with topical erythromycin and zinc: Effect on Propionibacterium acnes and free fatty acid composition. J Am Acad Dermatol. 1984;1(Suppl. 11):86-89.
  31. Thielitz A, Gollnick H. Systemische akne therapie. J Dtsch Dermatol Ges. 2005;3:366-378.
  32. Weller R. Nitric oxide — a newly discovered chemical transmitter in human skin. Br J Dermatol. 1997;137:665-672.
  33. Yamaoka J, Kume T, Akaike A, Miyachi Y. Suppressive effect of zinc ion on iNOS expression induced by interferon-gamma or tumor necrosis factor-alpha in murine keratinocytes. J Dermatol Sci.2000;23(Suppl. 1):27-35.
  34. Dreno B, Foulc P, Reynaud A, et al. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study. Eur J Dermatol. 2005;15(3):152-155.
  35. Basiron AS product labeling RUP №014057/ 01. (In Russ.)
  36. Differin product labeling RUP №012654/02. (In Russ.)
  37. Skinoren gel product labeling RUP №014589/02. (In Russ.)
  38. Dalacin product labeling RUP №011553/03. (In Russ.)
  39. Zineryt product labeling RUP №013569/01. (In Russ.)
  40. Lukyanov AM, Khvoynitskaya SV, Artamonova OV. Polyklinika. 2014;1. (In Russ.)
  41. Ipsos Connect study report (January 2017; 300 respondents). (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.